125000003729 nucleotide group Chemical group 0.000 claims description 295.239000002157 polynucleotide Substances 0.000 title claims description 379.229920000023 polynucleotide Polymers 0.000 title claims description 379.239000003795 chemical substances by application Substances 0.000 title claims description 499.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201462072686P external-priority Application filed by Genzyme Corp filed Critical Genzyme Corp Priority to EP21158656.5A priority Critical patent/EP3904519A1/en Publication of EP3212794A2 publication Critical patent/EP3212794A2/en Application granted granted Critical Publication of EP3212794B1 publication Critical patent/EP3212794B1/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links
Original Assignee Genzyme Corp Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Gregory Hinkle Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number EP15795074.2A Other languages German ( de)
OXYGEN NOT INCLUDED DOWNLOAD BUILD 210489 PDF
Google Patents Polynucleotide agents targeting serpinc1 (at3) and methods of use thereofĭownload PDF Info Publication number EP3212794B1 EP3212794B1 EP15795074.2A EP15795074A EP3212794B1 EP 3212794 B1 EP3212794 B1 EP 3212794B1 EP 15795074 A EP15795074 A EP 15795074A EP 3212794 B1 EP3212794 B1 EP 3212794B1 Authority EP European Patent Office Prior art keywords agent nucleotides antisense polynucleotide serpinc1 nucleotide Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents EP3212794B1 - Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof The persistence of the structural challenges of gender inequality requires governments to redouble their efforts to overcome them and honour their commitments in that regard.EP3212794B1 - Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof This complicates the picture for social spending and, above all, policies that impact the lives of women. The region’s economy is growing less, while levels of inequality and poverty are increasing. There is an international asymmetry among economic agents, in international trade, and in the capacity to innovate and generate new technologies, as well as between the main greenhouse-gas-emitting countries and those that are most vulnerable to the impacts of climate change. In the current regional context, progress towards the commitments set out in the Regional Gender Agenda and the 2030 Agenda must be accelerated as a matter of urgency, in order to face the many challenges posed by an economic scenario that is constantly changing due to economic, technological, demographic and climate changes.
0 kommentar(er)
